Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
Chen YP, Lv JW, Mao YP, Li XM, Li JY, Wang YQ, Xu C, Li YQ, He QM, Yang XJ, Lei Y, Shen JY, Tang LL, Chen L, Zhou GQ, Li WF, Du XJ, Guo R, Liu X, Zhang Y, Zeng J, Yun JP, Sun Y, Liu N, Ma J.
Chen YP, et al. Among authors: xu c.
Mol Cancer. 2021 Jan 11;20(1):14. doi: 10.1186/s12943-020-01292-5.
Mol Cancer. 2021.
PMID: 33430876
Free PMC article.